Target intelligence / Profile preview

Testosterone (T) (T)

Target
T
Molecular classification
Other
01

Overview

Testosterone is the principal androgenic steroid hormone responsible for the development of male secondary sexual characteristics and the maintenance of muscle mass and bone density (StatPearls, 2023). In systemic circulation, it exists in a "free" state or bound to proteins like sex hormone-binding globulin (SHBG) and albumin; "Testosterone free levels" specifically refer to the unbound fraction that is biologically active and capable of diffusing into target cells (Mayo Clinic, 2023). Once inside the cell, testosterone or its metabolite dihydrotestosterone (DHT) binds to the Androgen Receptor (AR), a ligand-dependent transcription factor that regulates the expression of genes involved in male physiology (PubChem, 2024). Clinically, this pathway is targeted either through testosterone replacement therapy to treat hypogonadism or through androgen deprivation therapy—using GnRH analogs or AR antagonists—to treat androgen-dependent prostate cancer (NIH, 2023). Because factors like age and obesity can significantly alter protein binding, measuring free levels is often considered a more accurate biomarker of a patient's functional androgenic status than measuring total testosterone alone (PubMed, 2022).

Other names
Free testosteroneUnbound testosteroneBioavailable testosteronefT17beta-Hydroxyandrost-4-en-3-onetrans-Testosterone
02

Mechanism of action

Drugs targeting this pathway act through androgen receptor agonism, androgen receptor antagonism, inhibition of testosterone biosynthesis (CYP17A1), inhibition of 5-alpha reductase, or suppression of the hypothalamic-pituitary-gonadal axis (StatPearls, 2023).

03

Biological functions

Signal transductionCell proliferationOther
04

Disease associations

CancerCardiovascular diseaseOther
05

Safety considerations

PolycythemiaProstate enlargementCardiovascular riskHepatotoxicitySuppression of spermatogenesis
06

Interacting drugs

Testosterone cypionate

4 more in the full profile.

07

Biomarkers

Free Testosterone Index (FTI)Sex Hormone-Binding Globulin (SHBG) levelsCalculated Free Testosterone (cFT)

Beyond the preview

Go deeper on Testosterone (T) (T).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Testosterone (T) (T).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call